Tumour heterogeneity: The rise of the minority - PubMed

• PMID: 23518702
• DOI: 10.1038/nrc3499

Free article

Comment

Tumour heterogeneity: The rise of the minority

Gemma K Alderton. Nat Rev Cancer. 2013 Apr.

Free article

Comment on

• Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

  Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS, Sougnez C, Stewart C, Sivachenko A, Wang L, Wan Y, Zhang W, Shukla SA, Vartanov A, Fernandes SM, Saksena G, Cibulskis K, Tesar B, Gabriel S, Hacohen N, Meyerson M, Lander ES, Neuberg D, Brown JR, Getz G, Wu CJ. Landau DA, et al. Cell. 2013 Feb 14;152(4):714-26. doi: 10.1016/j.cell.2013.01.019. Cell. 2013. PMID: 23415222 Free PMC article.

Similar articles

• Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.

  Van Keymeulen A, Lee MY, Ousset M, Brohée S, Rorive S, Giraddi RR, Wuidart A, Bouvencourt G, Dubois C, Salmon I, Sotiriou C, Phillips WA, Blanpain C. Van Keymeulen A, et al. Nature. 2015 Sep 3;525(7567):119-23. doi: 10.1038/nature14665. Epub 2015 Aug 12. Nature. 2015. PMID: 26266985

• Identification of cells initiating human melanomas.

  Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH, Frank MH. Schatton T, et al. Nature. 2008 Jan 17;451(7176):345-9. doi: 10.1038/nature06489. Nature. 2008. PMID: 18202660 Free PMC article.

• Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment.

  de Maar JS, Sofias AM, Porta Siegel T, Vreeken RJ, Moonen C, Bos C, Deckers R. de Maar JS, et al. Theranostics. 2020 Jan 1;10(4):1884-1909. doi: 10.7150/thno.38625. eCollection 2020. Theranostics. 2020. PMID: 32042343 Free PMC article. Review.

• Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.

  Tellez-Gabriel M, Ory B, Lamoureux F, Heymann MF, Heymann D. Tellez-Gabriel M, et al. Int J Mol Sci. 2016 Dec 20;17(12):2142. doi: 10.3390/ijms17122142. Int J Mol Sci. 2016. PMID: 27999407 Free PMC article. Review.

Cited by

• Molecular Targets for Breast Cancer Therapy.

  Montazeri Aliabadi H. Montazeri Aliabadi H. Biomolecules. 2024 Sep 27;14(10):1219. doi: 10.3390/biom14101219. Biomolecules. 2024. PMID: 39456152 Free PMC article.

• "Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.

  Bousoik E, Montazeri Aliabadi H. Bousoik E, et al. Front Oncol. 2018 Jul 31;8:287. doi: 10.3389/fonc.2018.00287. eCollection 2018. Front Oncol. 2018. PMID: 30109213 Free PMC article. Review.

References

Publication types

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Wiley

• Other Literature Sources

  • scite Smart Citations